The recipient of the 2023-2024 Sydney Finegold Postdoctoral Award, valued at $10,000, is Dr. Yanruide (Charlie) Li from Dr. Lili Yang’s Lab! Congratulations on this significant accomplishment Dr. Li!

UCLA researchers led by Dr. Lili Yang have discovered a promising new method to treat myeloid malignancies, a group of blood cancers, using off-the-shelf CAR-NKT cells. Learn more this #WorldCancerDay how this study could improve patient outcomes: bit.ly/4hLW0yf

The February issue cover of Trends in Pharmacological Sciences: an illustration of the synergy between CAR-T and various vaccine platforms to achieve the elimination of solid tumors. Cover designed by Xinyuan Shen, a graduate student in Lili Yang’s lab.UCLA

This #WorldOvarianCancerDay, we highlight the work of Dr. Sanaz Memarzadeh G.O. Discovery Lab and Dr. Lili Yang, who have teamed up to develop a novel immunotherapy they hope will transform ovarian cancer treatment. ➡️ bit.ly/3XsEVBS

A UCLA study suggests that common antidepressants could enhance the immune system’s ability to fight #cancer and suppress tumor growth. Repurposing these existing FDA-approved drugs could speed up the process of bringing new cancer treatments to patients. stemcell.ucla.edu/news/common-an…

New research from Lili Yang Engineering Immunity Lab, found that SSRIs enhanced the ability of T cells to fight #cancer & suppress tumor growth. Serotonin plays a role in processes throughout the body including digestion, metabolism, immune activity, & potentially even cancer. cell.com/cell/fulltext/…

SSRI Antidepressants May Also Be Anticancer “It turns out SSRIs don’t just make our brains happier; they also make our T cells happier—even while they’re fighting tumors,” say researchers led by Lili Yang, PhD, at UCLA. #antidepressants #cancer hubs.li/Q03nLrf80

Congrats to Dr. Bo Li and James Elsten-Brown on earning second place in UCLA TDG's #LABEST conference poster competition for their work on SERT regulation of serotonin-dependent antitumor immunity, based on their research in doi.org/10.1016/j.cell… Way to go, boys!

Hematology & Immunology Symposium at HK, June 10 held at CUHK Medicine Kathy Lui Lili Yang Engineering Immunity Lab Pereira Lab Lizhong Liu Mingxia Gu discuss blood origin, human embryo model, CAR-NKT, reprogramming immunotherapy, vascular organoid. Free register from QR

It's #TylerTuesday! Last week PhD Candidate Tyler Halladay shared his research on Engineering iPSC-derived gdT cells for solid tumor therapy with his UCLA Pharmacology community. Thanks for representing our lab, Tyler!

Could SSRI Antidepressants Help Fight Cancer? These drugs have been widely and safely used to treat depression for decades, repurposing them for cancer would be easier than developing an entirely new therapy. UCLA Lili Yang Engineering Immunity Lab #cancer #DrugRepurposing hubs.li/Q03py-WH0

Common Antidepressants Could Help the Immune System Fight Cancer, UCLA Study Finds Lili Yang Engineering Immunity Lab UCLA Broad Stem Cell oncodaily.com/science/antide… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #Antidepressant #Prozac #Celexa #SSRIs #UCLA

Could your antidepressant be moonlighting as a cancer fighter? 🧠🛡️ New UCLA research suggests SSRIs might help supercharge the immune system against cancer. Mood-lifting and life-saving? #TCSC #CancerResearch #Immunotherapy #SSRI #UCLA #MentalHealth insideprecisionmedicine.com/topics/oncolog…

A Boost for Cancer Treatments Selective serotonin reuptake inhibitors, long used as antidepressants, appear to help fight cancer by stimulating immune cell response.bit.ly/459TizU UCLA #prozac #fluoxetine #antidepressants #cancertreatment #serotonin Cell

Congratulations to Sean Shen for passing his oral qualifying exams and becoming a PhD Candidate! We're proud of you, XY Shen !

It's #TylerTuesday!!

Happy #TylerTuesday everyone! Hope you're all having a great week🫀

Guess What Day It Is #TylerTuesday

Congrats to PhD CANDIDATE John Zhu for passing his oral qualifying exams today! Proud of you, John!

Another week, another #TylerTuesday! This Tuesday, Tyler is knocking out mesothelin in his tumor models. Good luck, Tyler!